$50,000 of ABBOTT LABORATORIES lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to infant formula access. H.R.2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes."
You can find more data on corporate lobbying on Quiver Quantitative.
ABT Congressional Stock Trading
Members of Congress have traded $ABT stock 7 times in the past 6 months. Of those trades, 2 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ABT stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 08/14.
- REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 07/21.
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 07/18.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/24 and 1 sale worth up to $15,000 on 07/10.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $100,000 on 05/12.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ABT Insider Trading Activity
ABT insiders have traded $ABT stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ABT stock by insiders over the last 6 months:
- PHILIP P BOUDREAU (EVP AND CFO) sold 5,550 shares for an estimated $746,758
- SALLY E. BLOUNT sold 2,600 shares for an estimated $337,116
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ABT Hedge Fund Activity
We have seen 1,406 institutional investors add shares of ABT stock to their portfolio, and 1,369 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 8,968,261 shares (-17.7%) from their portfolio in Q2 2025, for an estimated $1,219,773,178
- CAPITAL INTERNATIONAL INVESTORS removed 6,687,339 shares (-10.0%) from their portfolio in Q2 2025, for an estimated $909,544,977
- PRICE T ROWE ASSOCIATES INC /MD/ added 6,178,992 shares (+148.2%) to their portfolio in Q2 2025, for an estimated $840,404,701
- WELLINGTON MANAGEMENT GROUP LLP removed 4,712,836 shares (-15.8%) from their portfolio in Q2 2025, for an estimated $640,992,824
- BLACKROCK, INC. added 4,309,866 shares (+3.1%) to their portfolio in Q2 2025, for an estimated $586,184,874
- BOSTON PARTNERS removed 3,107,794 shares (-99.0%) from their portfolio in Q2 2025, for an estimated $422,691,061
- VANGUARD GROUP INC added 2,977,715 shares (+1.8%) to their portfolio in Q2 2025, for an estimated $404,999,017
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ABT Analyst Ratings
Wall Street analysts have issued reports on $ABT in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Benchmark issued a "Buy" rating on 10/10/2025
- Evercore ISI Group issued a "Outperform" rating on 10/07/2025
- Raymond James issued a "Outperform" rating on 07/18/2025
- Wells Fargo issued a "Overweight" rating on 07/18/2025
- BTIG issued a "Buy" rating on 07/18/2025
- Jefferies issued a "Buy" rating on 07/18/2025
- RBC Capital issued a "Outperform" rating on 07/15/2025
To track analyst ratings and price targets for ABT, check out Quiver Quantitative's $ABT forecast page.
ABT Price Targets
Multiple analysts have issued price targets for $ABT recently. We have seen 9 analysts offer price targets for $ABT in the last 6 months, with a median target of $144.0.
Here are some recent targets:
- Bruce Jackson from Benchmark set a target price of $145.0 on 10/10/2025
- Vijay Kumar from Evercore ISI Group set a target price of $144.0 on 10/07/2025
- Anthony Petrone from Mizuho set a target price of $135.0 on 07/18/2025
- Jayson Bedford from Raymond James set a target price of $141.0 on 07/18/2025
- Lawrence Biegelsen from Wells Fargo set a target price of $142.0 on 07/18/2025
- Marie Thibault from BTIG set a target price of $145.0 on 07/18/2025
- Matthew Taylor from Jefferies set a target price of $145.0 on 07/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
